Combined Therapeutics
Cambridge, US · Founded 2016 · Delaware corporation
Combined Therapeutics Inc. (CTx) is a privately held biotechnology company developing mRNA vaccines and therapeutics using a proprietary multi-organ protection technology for tissue-specific mRNA expression. Its initial focus is on vaccines and vaccine adjuvants for infectious diseases and oncology.
Founders & leadership
Combined Therapeutics was founded in 2016 by Dan Anderson.
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2017
▶$250KraisedDec 2017 · 4 investors · BiotechnologyRule 506(b)
▶$250KraisedDec 2017 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel AndersonDirector
- Justine RyanDirector
- Romain MicolExecutive Officer, Director
- Pierre MatussiereDirector
- Robert LangerDirector
- Offering amount
- $2M
- Amount sold
- $250K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Solu15 shared keywordsSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Transcode Therapeutics14 shared keywordsTransCode Therapeutics is a clinical-stage company developing immuno-oncology and RNA-based therapeutics for high-risk and advanced cancers. Its lead candidate, TTX-MC138, targets microRNA-10b to treat patients with metastatic cancer and is in Phase 2a clinical trials.
Bioworld14 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Combined Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Combined Therapeutics do?
- Combined Therapeutics Inc. (CTx) is a privately held biotechnology company developing mRNA vaccines and therapeutics using a proprietary multi-organ protection technology for tissue-specific mRNA expression. Its initial focus is on vaccines and vaccine adjuvants for infectious diseases and oncology.
- Who founded Combined Therapeutics?
- Combined Therapeutics was founded by Dan Anderson in 2016.
- How much funding has Combined Therapeutics raised?
- Combined Therapeutics has disclosed $250K raised across 1 round.
- Where is Combined Therapeutics headquartered?
- Combined Therapeutics is headquartered in Cambridge, US.